EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Unlocking DCAFs To Catalyze Degrader Development: An Arena for Innovative Approaches

Qi Miao iD, Vilas D Kadam, Ayan Mukherjee, Zhi Tan, Mingxing Teng iD

Journal of Medicinal Chemistry · 12.10.2023 · 66 (19) · 13369-13383

DOI: 10.1021/acs.jmedchem.3c01209 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 22.09.2023. Verfasst von Qi Miao und 4 weiteren Autor:innen. Beteiligte Einrichtung: Center for Drug Discovery, Department of Pathology & Immunology, and Verna and Marrs McLean Department of Biochemistry and Molecular Pharmacology, Ba…. Hauptthemen laut MEDLINE: Ubiquitin-Protein Ligases, Drug Discovery, Proteolysis. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 125 Literaturangaben. Gefördert von: Cancer Prevention and Research Institute of Texas.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chemically induced proximity-based targeted protein degradation (TPD) has become a prominent paradigm in drug discovery. With the clinical benefit demonstrated by certain small-molecule protein degraders that target the cullin-RING E3 ubiquitin ligases (CRLs), the field has proactively strategized to tackle anticipated drug resistance by harnessing additional E3 ubiquitin ligases to enrich the arsenal of this therapeutic approach. Here, we endeavor to explore the collaborative efforts involved in unlocking a broad range of CRL4DCAF for degrader drug development. Throughout the discussion, we also highlight how both conventional and innovative approaches in drug discovery can be taken to realize this objective. Moving ahead, we expect a greater allocation of resources in TPD to pursue these high-hanging fruits.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ubiquitin-Protein LigasesDrug DiscoveryProteolysisHumansDrug Development

Substanzen

Ubiquitin-Protein Ligases

Autor:innen und Institutionen

  • Center for Drug Discovery, Department of Pathology & Immunology, and Verna and Marrs McLean Department of Biochemistry and Molecular Pharmacology, Baylor College of Medicine, Houston, Texas 77030, United States.

ORCID-Profile: Qi Miao, Mingxing Teng

Förderung

  • Cancer Prevention and Research Institute of Texas

Zitieren

APA

Miao, Q., Kadam, V. D., Mukherjee, A., Tan, Z., & Teng, M. (2023). Unlocking DCAFs To Catalyze Degrader Development: An Arena for Innovative Approaches. Journal of Medicinal Chemistry, 66(19), 13369-13383. https://doi.org/10.1021/acs.jmedchem.3c01209

Vancouver

Miao Q, Kadam VD, Mukherjee A, Tan Z, Teng M. Unlocking DCAFs To Catalyze Degrader Development: An Arena for Innovative Approaches. Journal of Medicinal Chemistry. 2023;66(19):13369-13383. doi:10.1021/acs.jmedchem.3c01209

BibTeX
@article{Miao2023,
  author = {Miao, Qi and Kadam, Vilas D and Mukherjee, Ayan and Tan, Zhi and Teng, Mingxing},
  title = {Unlocking DCAFs To Catalyze Degrader Development: An Arena for Innovative Approaches},
  journal = {Journal of Medicinal Chemistry},
  year = {2023},
  volume = {66},
  number = {19},
  pages = {13369--13383},
  doi = {10.1021/acs.jmedchem.3c01209}
}
Kostenlos starten →